LL-37 (cathelicidin)
LL-37 is an antimicrobial peptide the body makes itself, part of the skin's first line of defense. It has been tested in people only as a topical treatment for leg ulcers, with mixed results. It is sold online as an injection, which has never been studied.
- Legal lane: no approved product; FDA compounding review due by February 2027
- Evidence grade: C
- Studied form: applied to wounds
- Sold form: injectable powder
What it is
LL-37 is the only human cathelicidin, a family of peptides that kill bacteria and help coordinate wound repair. Chronic wounds tend to have low levels of it, which is the reasoning behind applying it directly.
What the evidence shows
- A 2014 trial in 34 people with hard-to-heal venous leg ulcers found faster healing with the two lower strengths applied twice a week, and no benefit at the highest strength.
- A larger 2021 trial in 148 people found no significant improvement in healing over placebo across the whole group.
Both trials put LL-37 on the wound. No human trial has tested it as an injection, for immune support, or for anything else it is sold for.
Dosing
No dose established. The only human dosing is topical concentrations applied to ulcers in clinical trials. Nothing in that work tells you what an injected dose would do.
Legal status
In April 2026 the FDA took LL-37 off its list of substances flagged as significant safety risks for compounding. That is not permission to compound it. An FDA advisory committee is scheduled to review it, with GHK-Cu, dihexa, Melanotan II and PEG-MGF, before the end of February 2027.
Common questions
Has LL-37 been tested in people?
Only as a topical treatment for leg ulcers, with mixed results. A 2014 trial in 34 people found faster healing at lower strengths. A larger 2021 trial in 148 people found no significant improvement over placebo.
Can pharmacies compound LL-37?
Not currently. Its April 2026 removal from the FDA's safety-risk list is not permission to compound it. An advisory committee is scheduled to review it before the end of February 2027.
Is there a dose for injected LL-37?
No. No human trial has tested LL-37 as an injection.
Added in the latest update. These answers summarize the sections above; sources are listed below.
Ask an AI about this page
Opens the assistant with a question about this page already typed in. You can edit it before sending.
Ask ChatGPTAsk ClaudeAsk Perplexity
These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.